Small Animal Internal Medicine

(EN09) Utilization of glycated Hemoglobin as a Biomarker to Identify and Monitor High-risk Groups for Diabetes

(EN10) Evaluation of Serum microRNA-375 Concentration in Dogs with Diabetes Mellitus

(EN11) Evaluating Efficacy Through Individualized Dosing Adjustment of Modified Radioiodine Therapy in Feline Hyperthyroidism

(EN12) Assessing a Third-generation Flash Glucose Monitoring System in Nondiabetic Dogs with Rapidly Induced Hypoglycemia

(EN13) Efficiency and Safety Evaluation of Thyroid Scintigraphy Using Small-Field-of-View Gamma Camera in Normal Cats

(GI22) Efficacy of a Flavored Oral Suspension of Metronidazole Against Giardia Duodenalis in Naturally Infected Dogs

(GI23) Safety Evaluation of a Flavoured Oral Suspension of Metronidazole in Dogs

(GI24) Prospective Evaluation of the Prevalence of Thromboembolism in Dogs with Inflammatory Protein-losing Enteropathy

(GI25) Investigation of Different Leukocyte Ratios as Diagnostic Markers in Cats with Chronic Enteropathy

(GI26) A Study of Real-Time Video Capsule Endoscopy for Diagnosing Acute Vomiting in Dogs

(GI27) Pilot Study Evaluating Fecal Microbiota and Clinical Response to Novel Probiotic in Dogs with Diarrhea

(GI28) Comparison of Clinicalpathological Features Between Healthy Yorkshire Terriers and Those with Portosystemic Shunt Throughout Treatment

(GI29) Diagnosis and Therapeutic Response of Chronic Colitis in French Bulldogs

(HM03) Diagnostic Assessment of Point-of-care Scanning System Integrated with Deep-learning Algorithms for Canine/feline Blood Film Evaluation.

(HM05) The in Vitro Effects of Acidemia and Acidemia Reversal on Coagulation in Dogs

(HM06) Evaluation of Circumferential Securing Tape Around Blood Pressure Cuffs on Doppler Ultrasound Blood Pressure Measurements

(HP07) Evaluation of Gallbladder Motility and Cholestasis by Hepatobiliary Scintigraphy in Dogs with Sludge

(HP08) Evaluation of Serum Immunoglobulin G in Dogs Diagnosed and Treated for Immune-mediated Chronic Hepatitis

(HP09) Evaluation of Coagulation Parameters in Dogs with Immune-mediated Chronic Hepatitis and Copper-associated Chronic Hepatitis

(HP10) Urinary copper:zinc Ratios in Dogs with Immune-mediated Chronic Hepatitis and Copper-associated Hepatitis

(ID06) Coexpression of Complement-Regulating Factors and FCoV-Antigen in Feline Infectious Peritonitis

(ID07) Fecal Microbial Transplant for Parvovirus in the Outpatient Setting Interim Analysis: A Randomized Controlled Trial

(ID08) Molecular Investigation of Tick-borne Pathogens from 6141 Dogs and 682 Cats in South Korea

(ID09) Molecular Prevalence of Upper Respiratory Tract Infection Pathogens in Dogs and Cats in South Korea

(ID10) Assessing Antimicrobial Resistance in Companion Animals at Referral Hospital: The Impact of Antimicrobial Stewardship Strategies

(ID11) Period-prevalence and Distribution of Babesia species Exposure in Thrombocytopenic Dogs in the Upper Midwest

(ID12) Successful In-hospital Treatment of FIP with FDA-approved Remdesivir (Veklury®) in 5 Cats

(IM04) Canine Parainfluenza One Year Duration of Immunity of a Combination BbPi Oral Vaccine Following Challenge

(IM05) Up-regulation of CCR5 and CCL5 May Contribute to Chronic Low-grade Inflammation in Aging Dogs

(IM06) Inhibition of Multiple Signaling Pathways May Attenuate mTOR and Promote Healthy Aging in Older Dogs

(IM07) Use of Eltrombopag-Based Combination Treatment for Immune-Mediated Thrombocytopenia in Dogs

(NE01) Epidemiological Characteristics and Risk Factors Associated with Neurological Manifestation of Canine Distemper Virus

(NE02) Diagnosis and Management of Movement Disorder (paroxysmal Dyskinesia) in Small-breed Dogs

(NM01) Evaluation of a Commercially Available Water Supplement to Promote Hydration in Clinically Ill Cats

(NM02) Evaluating Copper and Zinc Solubility in Canine Diets Using an in Vitro Model

(NU16) Vitamin D Metabolite Profiles in Cats with Chronic Kidney Disease Compared to Healthy Cats

(NU17) The Effect of Porus® One on Uremic Toxin Concentrations In Cats with Chronic Kidney Disease

(NU18) Evaluation of the Effect of Bilirubinuria on Urine Dipstick Results

(NU19) Analytical Validation of an Assay for Measurement of Uremic Toxins in Dog and Cat Serum

(NU20) Characterization of Cardiac Disease in Cats with Ureteral Obstruction Undergoing subcutaneous Ureteral Bypass Device Placement

(NU21) Comparing Defecation Frequency Between Cats with and Without Chronic Kidney Disease

(NU22) The Effect of Feeding on Urine Ammonia Levels in Cats with and Without CKD

(NU23) Comparison of Urine Sample Preparation Methods in Recovering Urine Sediment Elements from Canine/Feline Samples

(NU24) Pathophysiology of Hyperammonemia from Acute Kidney Injury or Acute on Chronic Kidney Disease in Cats

(NU25) Deep Learning Artificial Intelligence (AI) for Rapid and Reliable Evaluation of Canine/Feline Urine Sediment Samples

(NU26) Quantification of Serum Leptin Concentration in Cats with and without Chronic Kidney Disease

(NU27) Effects of Urine Biochemical Parameters in Use of Preservative Collection Tubes and Preservative Free Tubes

(NU28) Feline Chronic Kidney Disease Is Associated with Significant Caregiver Burden

(NU29) Evaluation of a Salivary Urea Nitrogen Test in Cats with Lower Urinary Tract Outflow Obstructions.

(NU30) Potential for Extending the Chloramphenicol Dosing Interval for Canine Urinary Tract Infections

(NU31) Retrospective Evaluation of Risk Factors for Kidney Injury After Angiotensin-converting Enzyme Inhibitor Treatment in Dogs

(NU32) Episioplasty Reduces the Incidence of Urinary Tract Infections and Perivulvar Pyoderma in Dogs

(NU33) Retrospective Evaluation of Hypoalbuminemia in Proteinuric Dogs

(NU34) The Effect of Porus® One on Amino Acid Concentrations In Cats with Chronic Kidney Disease

(OH09) Investigating the Pharmacokinetics and Pharmacodynamics of Glucoraphanin: A Crossover Study in Healthy Cats

(PH04) Bioavailability of Oral Ondansetron in Dogs, a Cross-over Study

(PH05) Pirfenidone Inhibits TGF-β1-Induced Fibrosis via Downregulation of Smad and ERK Pathway in MDCK Cells

(PH06) The Pharmacokinetics of Ampicillin Sulbactam in Azotemic and Non-Azotemic Dogs